BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 217 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,126,000 | -22.3% | 136,000 | -9.3% | 1.59% | +15.4% |
| Q4 2021 | $20,741,000 | +10.6% | 150,000 | +11.1% | 1.38% | +4.8% |
| Q3 2021 | $18,753,000 | -3.6% | 135,000 | -32.6% | 1.32% | -0.4% |
| Q2 2021 | $19,457,000 | +42.0% | 200,419 | 0.0% | 1.32% | +38.3% |
| Q1 2021 | $13,699,000 | -32.0% | 200,419 | -14.7% | 0.96% | -41.9% |
| Q4 2020 | $20,142,000 | -0.1% | 235,000 | -24.2% | 1.64% | -8.3% |
| Q3 2020 | $20,153,000 | +31.3% | 310,000 | +47.6% | 1.79% | +8.0% |
| Q2 2020 | $15,353,000 | +222.3% | 210,000 | +50.0% | 1.66% | +148.7% |
| Q1 2020 | $4,764,000 | -30.0% | 140,000 | +12.0% | 0.67% | -10.6% |
| Q4 2019 | $6,805,000 | – | 125,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $108,659,000 | 54.35% |
| Knoll Capital Management, LLC | 749,815 | $38,593,000 | 29.33% |
| VHCP Management II, LLC | 1,138,075 | $58,577,000 | 17.14% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,021,392 | $52,571,000 | 11.19% |
| Aisling Capital Management LP | 274,513 | $14,129,000 | 10.76% |
| Foresite Capital Management IV, LLC | 518,560 | $26,690,000 | 9.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 844,266 | $43,454,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 206,000 | $10,603,000 | 5.04% |
| ARS Investment Partners, LLC | 464,127 | $23,889,000 | 4.32% |
| Cormorant Asset Management, LP | 1,100,000 | $56,617,000 | 3.83% |